Novel Biomarkers Remarkable Tools.
Astute Medical focuses on novel biomarkers to create revolutionary, clinically useful tools to manage acute conditions. By researching, identifying and validating novel biomarkers of acute kidney injury (AKI) and other underserved disease states, we have developed products that break the time constraints between disease progression and more immediate responses.Using the latest AKI data and the Astute Approach, the Astute140® Meter & the NephroCheck® Test work cohesively to indicate the risk of AKI development. Because we’ve designed our tools to produce results within minutes, they allow rapid, life-saving responses—particularly within the ICU environment.
Astute140® Meter for Urgent Test Results
The critical care environment demands accurate information in a rapid fashion. To address this pressing need, we offer the Astute140® Meter, which in conjunction with the NephroCheck® Test, produces a quantitative test result that assesses short-term risk of developing AKI.Ready for near-immediate, always-accurate results?
For more information on the NephroCheck® Test and to view the Package Insert click here